The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata-Reference-Cited by-同舟云学术

The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata

Published:2023-06-08 Issue:7 Volume:13 Page:1503-1515
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Mesinkovska Natasha^ORCID,Craiglow Brittany^ORCID,Ball Susan G.^ORCID,Morrow Paula^ORCID,Smith Sarah G.^ORCID,Pierce Evangeline^ORCID,Shapiro Jerry^ORCID

Funder

Eli Lilly and Company

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

https://link.springer.com/content/pdf/10.1007/s13555-023-00941-z.pdf

Reference15 articles.

1. Islam N, Leung PS, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev. 2015;14(2):81–9.

2. Davey L, Clarke V, Jenkinson E. Living with alopecia areata: an online qualitative survey study. Br J Dermatol. 2019;180(6):1377–89.

3. Aldhouse NVJ, Kitchen H, Knight S, Macey J, Nunes FP, Dutronc Y, et al. “‘You lose your hair, what’s the big deal?’ I was so embarrassed, I was so self-conscious, I was so depressed:” a qualitative interview study to understand the psychosocial burden of alopecia areata. J Patient Rep Outcomes. 2020;4(1):76.

4. Mesinkovska N, King B, Mirmirani P, Ko J, Cassella J. Burden of illness in alopecia areata: a cross-sectional online survey study. J Investig Dermatol Symp Proc. 2020;20(1):S62–8.

5. Toussi A, Barton VR, Le ST, Agbai ON, Kiuru M. Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: a systematic review. J Am Acad Dermatol. 2021;85(1):162–75.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Scarring Alopecia in Females: A Comprehensive Review;EMJ Dermatology;2024-08-09

2. Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studies;Journal of the American Academy of Dermatology;2024-06

3. Use of diphenylcyclopropenone for alopecia areata treatment during pregnancy;JAAD Case Reports;2024-06

4. A cross‐sectional analysis of medications used by patients reporting alopecia areata on the FDA adverse events reporting system;International Journal of Dermatology;2024-01-12

5. Trichological problems at the intersection of dermatology and psychiatry: analysis of opportunities and ways of development;Psychiatry Neurology and Medical Psychology;2023-12-29